Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NR3C2 |
| Upstream (Parents) |
|---|
| (<<) GPHN → NR3C2 |
| (<<) NAAA → NR3C2 |
| (<<) EPHX2 → NR3C2 |
| (<<) MAOA → NR3C2 |
| (<<) CYP2J2 → NR3C2 |
| (<<) IRS1 → NR3C2 |
| Downstream (Children) |
|---|
| NR3C2 → RAB2A (>>) |
| NR3C2 → LAMA5 (>>) |
| NR3C2 → NFE2 (>>) |
| NR3C2 → WSCD1 (>>) |
| NR3C2 → L1CAM (>>) |
| NR3C2 → TUBB2B (>>) |
| NR3C2 → DOC2A (>>) |
| NR3C2 → BZRAP1 (>>) |
| NR3C2 → C22orf24 (>>) |
| NR3C2 → LOC729162///LOC389906///LOC286434 (>>) |
